259 results on '"Rapizzi, Elena"'
Search Results
2. [68Ga]DOTATOC PET-derived radiomics to predict genetic background of head and neck paragangliomas: a pilot investigation
3. The 3D in vitro Adrenoid cell model recapitulates the complexity of the adrenal gland
4. Correction: Hemodynamic parameters in patients undergoing surgery for pheochromocytoma/paraganglioma: a retrospective study
5. Hemodynamic parameters in patients undergoing surgery for pheochromocytoma/paraganglioma: a retrospective study
6. Genomic and immune landscape Of metastatic pheochromocytoma and paraganglioma
7. MAML3-fusions modulate vascular and immune tumour microenvironment and confer high metastatic risk in pheochromocytoma and paraganglioma
8. Early derangement of axonal mitochondria occurs in a mouse model of progressive but not relapsing-remitting multiple sclerosis
9. [68Ga]DOTATOC PET-derived radiomics to predict genetic background of head and neck paragangliomas: a pilot investigation.
10. Hypogonadism and sexual function in men affected by adrenocortical carcinoma under mitotane therapy
11. Regulation of epinephrine biosynthesis in HRAS-mutant paragangliomas
12. Cancer-associated fibroblasts promote prostate cancer malignancy via metabolic rewiring and mitochondrial transfer
13. Metabolome-guided genomics to identify pathogenic variants in isocitrate dehydrogenase, fumarate hydratase, and succinate dehydrogenase genes in pheochromocytoma and paraganglioma
14. The aggressiveness of SDHB deficient chromaffin cells is reduced when their bioelectrical properties are restored by glibenclamide
15. Recombinant Expression of the Voltage-Dependent Anion Channel Enhances the Transfer of Ca2+ Microdomains to Mitochondria
16. Regulation of epinephrine biosynthesis in HRAS-mutant paragangliomas.
17. Malignant Pheochromocytoma
18. Supplementary Figures 1 - 3 from MAX Mutations Cause Hereditary and Sporadic Pheochromocytoma and Paraganglioma
19. Tumour microenvironment in pheochromocytoma and paraganglioma
20. Co-occurrence of mutations in NF1 and other susceptibility genes in pheochromocytoma and paraganglioma
21. The aggressiveness of succinate dehydrogenase subunit B-deficient chromaffin cells is reduced when their bioelectrical properties are restored by glibenclamide.
22. Co-occurrence of mutations in NF1 and other susceptibility genes in pheochromocytoma and paraganglioma
23. The regulatory effect of sex steroids on the RhoA/ROCK pathway in the rat distal vagina
24. SDHB/SDHA immunohistochemistry in pheochromocytomas and paragangliomas: a multicenter interobserver variation analysis using virtual microscopy: a Multinational Study of the European Network for the Study of Adrenal Tumors (ENS@T)
25. Distal vagina smooth muscle contractility mechanisms: effects of in vivo sex steroids treatment in an animal experimental model of ovariectomy
26. Novel Germline PHD2 Variant in a Metastatic Pheochromocytoma and Chronic Myeloid Leukemia, but in the Absence of Polycythemia
27. Metformin Treatment Induces Different Response in Pheochromocytoma/Paraganglioma Tumour Cells and in Primary Fibroblasts
28. SDHB and SDHD silenced pheochromocytoma spheroids respond differently to tumour microenvironment and their aggressiveness is inhibited by impairing stroma metabolism
29. Succinate Dehydrogenase Subunit B Mutations Modify Human Neuroblastoma Cell Metabolism and Proliferation
30. Epigenetic Mutation of the Succinate Dehydrogenase C Promoter in a Patient With Two Paragangliomas
31. A Multicenter Epidemiological Study on Second Malignancy in Non-Syndromic Pheochromocytoma/Paraganglioma Patients in Italy
32. Analysis of Telomere Maintenance Related Genes Reveals NOP10 as a New Metastatic-Risk Marker in Pheochromocytoma/Paraganglioma
33. Loss of sdhb in zebrafish larvae recapitulates human paraganglioma characteristics
34. Spectrum and prevalence of FP/TMEM127 gene mutations in pheochromocytomas and paragangliomas
35. Krebs Cycle Metabolite Profiling for Identification and Stratification of Pheochromocytomas/Paragangliomas due to Succinate Dehydrogenase Deficiency
36. Pitfalls in Genetic Analysis of Pheochromocytomas/Paragangliomas—Case Report
37. Sphingosine 1-phosphate increases glucose uptake through trans-activation of insulin receptor
38. Sphingosine 1-phosphate differentially regulates proliferation of C2C12 reserve cells and myoblasts
39. Loss of sdhb in zebrafish larvae recapitulates human paraganglioma characteristics
40. Metabolomics, machine learning and immunohistochemistry to predict succinate dehydrogenase mutational status in phaeochromocytomas and paragangliomas
41. Metabolomics, machine learning and immunohistochemistry to predict succinate dehydrogenase mutational status in phaeochromocytomas and paragangliomas
42. Functional significance of germline EPAS1 variants
43. Loss of sdhb in zebrafish larvae recapitulates human paraganglioma characteristics
44. Pheochromocytoma/paraganglioma preclinical models: which to use and why?
45. Tumoral EPAS1 (HIF2A) mutations explain sporadic pheochromocytoma and paraganglioma in the absence of erythrocytosis
46. Yeast model for evaluating the pathogenic significance of SDHB, SDHC and SDHD mutations in PHEO–PGL syndrome
47. The Ca2+ concentration of the endoplasmic reticulum is a key determinant of ceramide‐induced apoptosis: significance for the molecular mechanism of Bcl‐2 action
48. Metabolomics, machine learning and immunohistochemistry to predict succinate dehydrogenase mutational status in phaeochromocytomas and paragangliomas
49. Germline Mutation in KIF1Bβ Gene Associated with Loss of Heterozygosity: Usefulness of Next-Generation Sequencing in the Genetic Screening of Patients with Pheochromocytoma
50. Testosterone improves muscle fiber asset and exercise performance in a metabolic syndrome model
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.